Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine-Based Dexamethasone-Sparing Regimen for CINV in Breast Cancer
NCT07743827Recruiting
- Sponsor
- Alexandria University
- Start
- May 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Randomised trial of olanzapine in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by Alexandria University. Primary endpoints: Complete response during the delayed phase CINV and Total Control during the delayed phase. Started May 2026; status: recruiting.
02
Drugs
olanzapine
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT07743827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07743827.